Kejing Wang

Myelodysplastic Syndrome/Acute Myeloid Leukemia Following the Use of Poly-ADP Ribose Polymerase (PARP) Inhibitors: A Real-World Analysis of Postmarketing Surveillance Data

Lin Chen, Yang Yang, Quanfeng Zhao, 2022, Frontiers in Pharmacology.

Systematic analysis of safety profile for darunavir and its boosted agents using data mining in the FDA Adverse Event Reporting System database

G. He, Lin Chen, Yun-tao Jia, 2021, Scientific Reports.

Real-world Safety Profile of Darunavir and its Boosted Agents: An Analysis of FDA Adverse Event Reporting System Database

G. He, Lin Chen, Yun-tao Jia, 2021 .

Pre-transplant CRP–albumin ratio as a biomarker in patients receiving haploidentical allogeneic hematopoietic transplantation: Developing a novel DRCI-based nomogram

Huafang Wang, Xing Jian, Kejing Wang, 2023, Frontiers in Immunology.

Development and validation of nomograms for predicting the risk probability of carbapenem resistance and 28-day all-cause mortality in gram-negative bacteremia among patients with hematological diseases

Huafang Wang, Xin Dong, Shuaixian Du, 2023, Frontiers in Cellular and Infection Microbiology.

Genetic engineering of pigs for xenotransplantation to overcome immune rejection and physiological incompatibilities: The first clinical steps

Lin Chen, L. Buhler, Tiantian Lei, 2022, Frontiers in Immunology.

Pregnancy outcomes and birth defects in offspring following Non-steroidal anti-inflammatory drugs exposure during pregnancy: A systematic review and meta-analysis.

Xiaohong Chen, Kejing Wang, Lin Chen, 2024, Reproductive toxicology.